FIRMAGON is administered as a subcutaneous injection exclusively in the abdominal region.
Understanding FIRMAGON Administration
FIRMAGON (degarelix) is a medication delivered just under the skin, a method known as a subcutaneous injection. For this specific drug, it is critical to limit the injection site to the abdominal area only. This ensures proper absorption and effectiveness of the medication as intended.
Dosage and Administration Schedule
The initial and subsequent doses of FIRMAGON follow a precise schedule and quantity, delivered through the subcutaneous route in the abdominal region.
Starting Dose
The starting dose of FIRMAGON is 240 mg. This total dose is administered as two separate subcutaneous injections.
| Dose | Quantity per Injection | Concentration | Total Injections | Total Dose |
|---|---|---|---|---|
| Starting Dose | 120 mg | 40 mg/mL | 2 | 240 mg |
Each of the two 120 mg injections should be given in different sites within the abdominal region to manage the total volume.
Maintenance Dosing
After the initial starting dose, the timing for subsequent injections is crucial for continuous treatment:
- The first maintenance dose should be given 28 days after the starting dose.
This structured administration schedule, coupled with the precise injection site, is vital for the effective management of conditions treated by FIRMAGON.
